BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Biofuel
,
Rapamycin
,
rs3825942
,
CYP51
,
cell-cell adhesion
,
Breast Cancer
,
Prostate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ubiquitin binding
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Testes
Jejunum
Skeletal muscle
Colon cecum
Stomach cardiac
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Circulating miRNA in serum of Wilms tumor patients
Breast tumor miRNA gene expression profiles
Follicular fluid miRNA profiles during the development of the oocyte
Lung adenocarcinoma and adjacent normal tissue miRNA expression profiles
PBMC microRNA expression from pulmonary tuberculosis and sarcoidosis patients
Explore Curated Studies Results
Literature
Most Relevant Literature
Role of UbL family modifiers and their binding proteins in cell signaling.
Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions.
UMI, a novel RNF168 ubiquitin binding domain involved in the DNA damage signaling pathway.
Ubiquitin-binding domains - from structures to functions.
Ubiquitin-binding domains and their role in the DNA damage response.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
ADAPT: Efficacy of a Dietary Supplement During and After Exercise
Neuronal Damage In Delirium Study
Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC
Drivers of Hypoxia-induced Angiogenesis in Tumor Development
A Study of TQB3820 in Patients With Hematological Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ